Linking Solubility and Permeability Assays for Maximum Throughput and Reproducibility

Abstract

Solubility and permeability are intimately linked in drug absorption processes. They have, however, been traditionally assayed separately. To support this linkage, a combined solubility/permeability assay was developed for determining absorption properties of chemical entities. First, solubility is determined at 4 pH values by comparing the concentration of a saturated compound solution to its dilute, known concentration. The filtered, saturated solution from the solubility assay is then used as input material for the membrane permeability determination. The permeability assay is a parallel artificial membrane technique whereby a membrane is created on a solid support parallel artificial membrane permeation assay (PAMPA). The 2 artificial membranes presented here model the gastrointestinal tract and the blood-brain barrier (BBB). Data are presented for control compounds, which are well documented in the literature and exemplify a range of solubility and membrane permeability. The advantages of the combination method are 1) reduction of sample usage and preparation time, 2) elimination of interference from compound precipitation in membrane permeability determination, 3) maximization of input concentration to permeability assay for improved reproducibility, and 4) optimization of sample tracking by streamlining data entry and calculations. BBB permeability ranking of compounds correlates well with literature CNS activity.

Keywords

PAMPA ADME-Tox blood-brain-barrier high throughput

References

Kilpatrick P : Pressures in the pipeline. Nat Rev Drug Discov 2003;2:337-337.

Avdeef A : Physicochemical profiling (solubility, permeability, and charge state). Curr Top Med Chem 2001;1:277-351.

Avdeef A : Absorption and Drug Development: Solubility, Permeability, and Charge State. Hoboken, NJ: John Wiley & Sons, 2003.

Bohets H , Annaert P , Mannens G , van Beijsterveldt L , Anciaux K , Verboven P , et al: Strategies for absorption screening in drug discovery and development. Curr Top Med Chem 2001;1:367-383.

Sun D , Yu LX , Hussain MA , Wall DA , Smith RL , Amidon GL : In vitro testing of drug absorption for drug “develop ability” assessment: forming an interface between in vitro preclinical data and clinical outcome. Curr Opin Drug Discov Devel 2004;7:75-85.

Hidalgo IJ : Assessing the absorption of new pharmaceuticals. Curr Top Med Chem 2001;1:385-401.

Levy RH , Rowland M : Dissociation constants of sparingly soluble substances: non-logarithmic linear titration curves. J Pharm Sci 1971;60:1155-1159.

Charykov AK , Tal’nikova TV : pH-metric method of determining the solubility and distribution ratios of some organic compounds in extraction systems. J Anal Chem 1974;29:818-822.

Faller B , Wohnsland F : Physicochemical parameters as tools in drug discovery and lead optimization. In Testa B , van de Waterbeemd H , Folkers G , Guy R (eds): Pharmacokinetics Optimization in Drug Research. Zurich, Switzerland: Verlag Helvitica Chimica Acta, 2001:257-274.

10.

Bevan CD , Lloyd RS : A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal Chem 2000;72:1781-1787.

11.

Hayward MJ , Hargiss LO , Munson JL , Mandiyan SP , Wennogle LP : Validation of solubility measurements using ultra-filtration liquid chromatography mass spectrometry (UF-LC/MS). Paper presented at the 48th annual conference on Mass Spectrometry and Allied Topics, Long Beach, CA, 2000:AM10:55-55.

12.

Lipinski CA , Lombardo F , Dominy BW , Feeney PJ : Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;23:3-26.

13.

Avdeef A : High throughput measurements of solubility profiles. In Testa B , van de Waterbeemd H , Folkers G , Guy R (eds): Pharmacokinetics Optimizationin Drug Research. Zurich, Switzerland: Verlag Helvitica Chimica Acta, 2001:305-326.

14.

Mason RP , Rhodes DG , Herbette LG : Reevaluating equilibrium and kinetic binding parameters from lipophilic drugs based on a structural model for drug interactions with biological membranes. J Med Chem 1991;34:869-877.

15.

Herbette LG , Rhodes DG , Mason RP : New approaches to drug design and delivery based on drug-membrane interactions. Drug Des Deliv 1991;7:75-118.

16.

Austin RP , Davis AM , Manners CN : Partitioning of ionizing molecules between aqueous buffers and phospholipids vesicle. J Pharm Sci 1995;84:1180-1183.

17.

Balon K , Riebesehl BU , Muller BW : Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharm Res 1999;16:882-888.

18.

Kansey M , Senner F , Gubernator K : Physicochemical high throughput screening: parallel artificial permeation assay in the description of passive absorption processes. J Med Chem 1998;41:1007-1010.

19.

Artursson P , Karlsson J : Correlation between oral absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco2) cells. Biochem Biophys Res Commun 1991;175:880-885.

20.

Yee S : In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man—fact or myth? Pharm Res 1997;14:763-766.

21.

Sugano K , Hamada H , Machida M , Ushio H : High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeability assay. J Biomol Screen 2001;6:189-196.

22.

Sugano K , Hamada H , Machida M , Ushio H , Saitoh K , Terada K : Optimized conditions of biomimetic artificial membrane permeability assay. Int J Pharm 2001;228:181-188.

23.

Wohlsland F , Faller B : High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. J Med Chem 2001; 44:923-930.

24.

Zhu C , Jiang L , Chen T-M , Hwang K-K : A comparative study of artificial membrane permeability assay for high-throughput profiling of drug absorption potential. Eur J Med Chem 2002;37:399-407.

25.

Di L , Kerns EH , Fan K , McConnell OJ , Carter GT : High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem 2003;38:223-232.

26.

Millipore Corporation : MultiScreen solubility filter plate: determination of aqueous compound solubility using a 96-well filter plate to remove precipitated solids prior to UV/Vis spectroscopic analysis. Millipore Corporation protocol note PC2445EN00.

27.

Molecular Devices : Making optical density measurements automatically corrected to a 1cm pathlength in the SPECTRAmaxPLUS microplate spectrophotometer. Application Note 25: 0120-1120A.

28.

Avdeef A , Berger CM , Brownell C : pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility pH methods. Pharm Res 2000;17:85-89.

29.

Sugano K , Nabuchi Y , Machida M , Aso Y : Prediction of human intestinal permeability using artificial membrane permeability. Int J Pharm 2003;257:245-251.

30.

Ruell JA , Tsinman KL , Avdeef A : PAMPA: a drug absorption in vitro model 5. Unstirred water layer in iso-pH mapping assays and pKaflux–optimized design (pOD-PAMPA). Eur J Pharm Sci 2003;20:393-402.

31.

McCall AL , Millington WR , Wurtman RJ : Blood-brain barrier transport of caffeine: dose-related restriction of adenine transport. Life Sci 1982;31:2709-2715.

32.

Kelder J , Grootenhuis PDJ , Bayada DM , Delbressine LPC , Ploemen JP : Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res 1999;16:1514-1519.